Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

768 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
Margonis GA, Amini N, Buettner S, Kim Y, Wang J, Andreatos N, Wagner D, Sasaki K, Beer A, Kamphues C, Morioka D, Løes IM, Imai K, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Burkhart R, Endo I, Baba H, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ. Margonis GA, et al. Among authors: beer a. Ann Surg. 2021 Jun 1;273(6):1165-1172. doi: 10.1097/SLA.0000000000003504. Ann Surg. 2021. PMID: 31389831
Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
Stift J, Graf A, Schwarz C, Tamandl D, Starlinger P, Herac M, Beer A, Wrba F, Bodingbauer M, Kaczirek K, Stremitzer S. Stift J, et al. Among authors: beer a. Eur J Surg Oncol. 2018 Jan;44(1):139-147. doi: 10.1016/j.ejso.2017.11.018. Epub 2017 Nov 26. Eur J Surg Oncol. 2018. PMID: 29203074
Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.
Deshwar A, Margonis GA, Andreatos N, Barbon C, Wang J, Buettner S, Wagner D, Sasaki K, Beer A, Løes IM, Pikoulis E, Damaskos C, Garmpis N, Kamphues K, He J, Kaczirek K, Poultsides G, Lønning PE, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ. Deshwar A, et al. Among authors: beer a. Anticancer Res. 2018 May;38(5):2891-2895. doi: 10.21873/anticanres.12535. Anticancer Res. 2018. PMID: 29715113
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA, Buettner S, Andreatos N, Kim Y, Wagner D, Sasaki K, Beer A, Schwarz C, Løes IM, Smolle M, Kamphues C, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Cameron JL, Burkhart RA, Gerger A, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ. Margonis GA, et al. Among authors: beer a. JAMA Surg. 2018 Jul 18;153(7):e180996. doi: 10.1001/jamasurg.2018.0996. Epub 2018 Jul 18. JAMA Surg. 2018. PMID: 29799910 Free PMC article.
Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.
Bhangu JS, Beer A, Mittlböck M, Tamandl D, Pulverer W, Schönthaler S, Taghizadeh H, Stremitzer S, Kaczirek K, Gruenberger T, Gnant M, Bergmann M, Mannhalter C, Weinhäusel A, Oehler R, Bachleitner-Hofmann T. Bhangu JS, et al. Among authors: beer a. Ann Surg. 2018 Nov;268(5):894-902. doi: 10.1097/SLA.0000000000002901. Ann Surg. 2018. PMID: 30080722
Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
Margonis GA, Buettner S, Andreatos N, Wagner D, Sasaki K, Barbon C, Beer A, Kamphues C, Løes IM, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Cameron JL, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ. Margonis GA, et al. Among authors: beer a. Ann Surg. 2019 Jun;269(6):1129-1137. doi: 10.1097/SLA.0000000000002664. Ann Surg. 2019. PMID: 31082912
Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?
Amini N, Andreatos N, Margonis GA, Buettner S, Wang J, Galjart B, Wagner D, Sasaki K, Angelou A, Sun J, Kamphues C, Beer A, Morioka D, Løes IM, Antoniou E, Imai K, Pikoulis E, He J, Kaczirek K, Poultsides G, Verhoef C, Lønning PE, Endo I, Baba H, Kornprat P, NAucejo F, Kreis ME, Christopher WL, Weiss MJ, Safar B, Burkhart RA. Amini N, et al. Among authors: beer a. J Hepatobiliary Pancreat Sci. 2022 Apr;29(4):417-427. doi: 10.1002/jhbp.1054. Epub 2021 Oct 20. J Hepatobiliary Pancreat Sci. 2022. PMID: 34614304
768 results